Duration of Chemotherapy-induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles [PDF]
The Oncologist, 2022 AbstractBackgroundThe relationship between CINV duration and recurrence in subsequent cycles is largely unstudied. Our objective was to determine if patients experiencing CINV in their first cycle of chemotherapy (C1) would face increased risk of CINV in later cycles and whether the duration of the CINV would predict increased risk of recurrence ...
Rudolph Navari +11 more
openaire +4 more sources
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime? [PDF]
South Asian Journal of Cancer, 2020 Background Various predictive models have been developed which incorporates patient risk factors into the selection of optimal antiemetic therapy, one of which is chemotherapy-induced nausea and vomiting (CINV) risk scoring system developed by ...
Anita D’Souza +8 more
doaj +2 more sources
Incidence and Risk Factors of Delayed Chemotherapy-Induced Nausea and Vomiting Among Adult Patients: A Cross-Sectional Study. [PDF]
Nurs OpenABSTRACT Aim To assess the incidence of delayed chemotherapy‐induced nausea and vomiting (CINV) and identify key risk factors among adult patients. Design A descriptive cross‐sectional design. Methods A total of 326 adult patients undergoing chemotherapy were recruited using consecutive sampling from a nearly 4000‐bed tertiary general hospital in ...
Zheng M +9 more
europepmc +2 more sources
Prediction of Moderate to Severe Delayed Chemotherapy-Induced Nausea Using a Novel Algorithm Incorporating Individual Patient Factors. [PDF]
Cancer MedABSTRACT Purpose Chemotherapy‐induced vomiting and nausea (CINV) is difficult to accurately predict, especially in the delayed phase and can negatively affect a patient's' quality of life as well as reduce their motivation to continue lifesaving therapy.
Maity AP +9 more
europepmc +2 more sources
Multi-omics Analysis Reveals the Correlation of Gut Microbiota and Metabolites With Thalidomide Treatment for Chemotherapy-Induced Nausea and Vomiting in Small Cell Lung Cancer. [PDF]
Biotechnol JGraphical Abstract and Lay Summary We characterize the gut microbiota signatures associated with Thalidomide treatment in small cell lung cancer patients experiencing chemotherapy‐induced nausea and vomiting. The analysis reveals significant changes in specific genera, linking microbial composition to symptom management. ABSTRACT Small cell lung cancer
Sun QG +5 more
europepmc +2 more sources
Frontiers in Psychiatry, 2023 ObjectiveTo investigate the impact of chemotherapy induced nausea and vomiting (CINV) on the anxiety and depression of the primary family caregivers of patients with cancer.MethodsThis study screened family caregivers of patients with cancer undergoing ...
Xiaozhen Luo +6 more
doaj +1 more source
European Journal of Medical and Health Sciences, 2023 Chemotherapy-induced nausea and vomiting (CINV) prevention is important to reduce overall morbidity and financial burden in patients receiving chemotherapy. Severe symptoms reduce the patient's quality of life and can interfere with further treatment.
I Nyoman Bayu Mahendra +1 more
openaire +1 more source
Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends
Cancer Treatment and Research Communications, 2021 The significant physical and emotional effects of chemotherapy-induced nausea and vomiting (CINV) are experienced by cancer patients. Severe symptoms decrease the patient's quality of life and potentially deters further treatment.
Kush Gupta, Rebecca Walton, S.P. Kataria
doaj +1 more source
South Asian Journal of Cancer, 2020 Purpose The objective of this study was to assess the proportion of patients developing chemotherapy-induced nausea and vomiting (CINV) after receiving chemotherapy for gastrointestinal (GI) cancers, despite receiving antiemetic prophylaxis (AEP) as per ...
Akhil Kapoor +9 more
doaj +1 more source
Transient Receptor Potential Vanilloid 1 Function at Central Synapses in Health and Disease
Frontiers in Cellular Neuroscience, 2022 The transient receptor potential vanilloid 1 (TRPV1), a ligand-gated nonselective cation channel, is well known for mediating heat and pain sensation in the periphery. Increasing evidence suggests that TRPV1 is also expressed at various central synapses,
Rodrigo C. Meza +4 more
doaj +1 more source